Allergan Ruling Reinforces Value Of Patent Term Adjustments
On Aug. 13, the U.S. Court of Appeals for the Federal Circuit held in Allergan USA Inc. v. MSN Laboratories Private Ltd.[1] that "a first-filed, first-issued, later-expiring claim" cannot be invalidated...To view the full article, register now.
Already a subscriber? Click here to view full article